Public list: BIO 2016 (619) Pharma Startups (6570)
HemoShear Therapeutics discovers biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-TX, enables the company to create best-in-class, biologic...Show all
Company (Alive / Active)
Phone: 434-872-0196
501 Locust Avenue
Suite 301
Charlottesville, 22902
Virginia, United States
Total Funding | Date of Last Funding | |
---|---|---|
HemoShear Therapeutics | $26.3M | Apr 8, 2020 |
See all 13 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|---|---|---|
National Heart Lung and Blood Institute | Government | Bethesda, Maryland, United States | Grant - II, Grant |
CIT GAP Funds | Venture Capital | Herndon, Virginia, United States | Other Investors |
National Institutes of Health | Government | Bethesda, Maryland, United States | Grant - II, Grant |
National Organization for Rare Disorders | Non-Profit Foundation | Danbury, Connecticut, United States | Grant - III |
Paycheck Protection Program | Government | Washington, DC, United States | Loan |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
In vitro model for pathological or physiologic conditions | May 19, 2017 | Nov 17, 2020 | Patent |
In vitro model for pathological or physiologic conditions | Nov 18, 2016 | Dec 24, 2019 | Patent |
In vitro model for a tumor microenvironment | Apr 10, 2017 | Mar 05, 2019 | Patent |
In vitro model for pathological or physiologic conditions | Apr 18, 2013 | May 23, 2017 | Patent |
In vitro model for a tumor microenvironment | Oct 21, 2014 | Apr 11, 2017 | Patent |